NSTM Projected Dividend Yield
NovelStem International Corp ( OTCBB : NSTM )NovelStem International Corp. is a development-stage biotechnology holding company focused on stem cell-based technology. Co.'s primary assets are NewStem Ltd (NewStem) and NetCo Partners (NetCo). NewStem focuses on the development and commercialization of diagnostic technology that can predict patients' anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy. NewStem is principally focused on utilizing proprietary human Pluripotent Stem Cells (hPSCs) and Haploid human Pluripotent Stem Cells (HhPSCs) in the development of diagnostic and therapeutic products in oncology. 17 YEAR PERFORMANCE RESULTS |
NSTM Dividend History Detail NSTM Dividend News NSTM Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |